278 resultater (0,34080 sekunder)

Mærke

Butik

Pris (EUR)

Nulstil filter

Produkter
Fra
Butikker

Vaccine Safety Forum - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics - Development Forum On Drug Discovery - Bog - National

Adult Attention-Deficit/Hyperactivity Disorder - Forum On Neuroscience And Nervous System Disorders - Bog - National Academies Press - Plusbog.dk

Toward a Common Research Agenda in Infection-Associated Chronic Illnesses - Forum On Neuroscience And Nervous System Disorders - Bog - National

Medical Countermeasures Dispensing - Forum On Medical And Public Health Preparedness For Catastrophic Events - Bog - National Academies Press -

CNS Clinical Trials - Forum On Neuroscience And Nervous System Disorders - Bog - National Academies Press - Plusbog.dk

Alternative Protein Sources - Food Forum - Bog - National Academies Press - Plusbog.dk

Multi-Center Phase III Clinical Trials and NCI Cooperative Groups - National Cancer Policy Forum - Bog - National Academies Press - Plusbog.dk

Multi-Center Phase III Clinical Trials and NCI Cooperative Groups - National Cancer Policy Forum - Bog - National Academies Press - Plusbog.dk

The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovative treatments that improve outcomes and quality of life. Despite these successes, the Cooperative Group Program has faced a number of challenges that threaten its effectiveness. To address this problem, the National Cancer Policy Forum (NCPF) convened a workshop titled "Multi-Center Phase III Clinical Trials and NCI Cooperative Groups" in Washington, DC, on July 1-2, 2008. The purpose of the workshop was to outline the challenges that the public clinical cancer research enterprise faces, and to identify possible solutions to these challenges. Table of ContentsFront MatterIntroductionSession 1A: Organization of the NCI Clinical Trials SystemSession 1B: Lessons from Non-Cooperative Group Multi-Center Clinical TrialsSession 2: Barriers to Patient Recruitment and Physician ParticipationSession 3: Data Collection Standards and MonitoringSession 4: Costs of Cooperative Group Clinical TrialsSummary and Wrap-UpReferencesAbbreviations and AcronymsGlossaryAppendix A: Workshop AgendaAppendix B: Workshop SpeakersAppendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum

DKK 461.00
1

A Summary of the February 2010 Forum on the Future of Nursing - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

A Summary of the February 2010 Forum on the Future of Nursing - Institute Of Medicine - Bog - National Academies Press - Plusbog.dk

As the U.S. health care system continues to evolve, the role of nurses also needs to evolve. Nurses must strike a delicate balance among advancing science, translating and applying research, and caring for individuals and families across all settings. Preparing nurses to achieve this balance is a significant challenge. The education system should ensure that nurses have the intellectual capacity, human responsiveness, flexibility, and leadership skills to provide care and promote health whenever and wherever needed. Education leaders and faculty need to prepare nurses with the competencies they need now and in the future. They need to prepare nurses to work and assume leadership roles not just in hospitals, but in communities, clinics, homes, and everywhere else nurses are needed. On February 22, 2010 the Initiative on the Future of Nursing held the last public forum in a series of three at the University of Texas MD Anderson Cancer Center. This forum, which covered the education of nurses, consisted of three armchair discussions. Each discussion was led by a moderator from the committee and focused on three broad, overlapping subjects: what to teach, how to teach, and where to teach. The verbal exchange among the discussants and moderators, prompted by additional questions from committee members at the forum, produced a wide-ranging and informative examination of questions that are critical to the future of nursing education. Additionally, testimony presented by 12 individuals and comments made by members of the audience during an open microphone session provided the committee with valuable input from a range of perspectives. Table of ContentsFront Matter1 Introduction2 What to Teach3 How to Teach 4 Where to Teach5 TestimonyAppendix A ReferencesAppendix B Agenda Appendix C Speaker Biosketches

DKK 208.00
1

Ensuring Quality Cancer Care Through the Oncology Workforce - National Cancer Policy Forum - Bog - National Academies Press - Plusbog.dk

Early Interventions for Psychosis - Forum On Mental Health And Substance Use Disorders - Bog - National Academies Press - Plusbog.dk

Providing Healthy and Safe Foods As We Age - Food Forum - Bog - National Academies Press - Plusbog.dk

Transforming Clinical Research in the United States - Development Forum On Drug Discovery - Bog - National Academies Press - Plusbog.dk

Transforming Clinical Research in the United States - Development Forum On Drug Discovery - Bog - National Academies Press - Plusbog.dk

An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between clinical practice and research. There are growing indications, however, that the current health care system and the clinical research that guides medical decisions in the United States falls far short of this vision. The process of generating medical evidence through clinical trials in the United States is expensive and lengthy, includes a number of regulatory hurdles, and is based on a limited infrastructure. The link between clinical research and medical progress is also frequently misunderstood or unsupported by both patients and providers. The focus of clinical research changes as diseases emerge and new treatments create cures for old conditions. As diseases evolve, the ultimate goal remains to speed new and improved medical treatments to patients throughout the world. To keep pace with rapidly changing health care demands, clinical research resources need to be organized and on hand to address the numerous health care questions that continually emerge. Improving the overall capacity of the clinical research enterprise will depend on ensuring that there is an adequate infrastructure in place to support the investigators who conduct research, the patients with real diseases who volunteer to participate in experimental research, and the institutions that organize and carry out the trials. To address these issues and better understand the current state of clinical research in the United States, the Institute of Medicine's (IOM) Forum on Drug Discovery, Development, and Translation held a 2-day workshop entitled Transforming Clinical Research in the United States. The workshop, summarized in this volume, laid the foundation for a broader initiative of the Forum addressing different aspects of clinical research. Future Forum plans include further examining regulatory, administrative, and structural barriers to the effective conduct of clinical research; developing a vision for a stable, continuously funded clinical research infrastructure in the United States; and considering strategies and collaborative activities to facilitate more robust public engagement in the clinical research enterprise. Table of ContentsFront Matter1 Introduction2 The State of Clinical Research in the United States: An Overview3 Challenges in Clinical Research4 Clinical Trials in Cardiovascular Disease5 Clinical Trials in Depression6 Clinical Trials in Cancer7 Clinical Trials in Diabetes8 Building a Robust Clinical Trials InfrastructureReferencesAppendix A AgendaAppendix B Participant Biographies

DKK 318.00
1

Managing Food Safety Practices from Farm to Table - Food Forum - Bog - National Academies Press - Plusbog.dk

Transitioning to Sustainability Through Research and Development on Ecosystem Services and Biofuels - Science And Technology For Sustainability

Nanotechnology and Oncology - National Cancer Policy Forum - Bog - National Academies Press - Plusbog.dk

Nanotechnology and Oncology - National Cancer Policy Forum - Bog - National Academies Press - Plusbog.dk

One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts. Table of ContentsFront Matter1 Introduction2 Uses of Nanotechnology in Oncology and Cancer Research3 Research and Development of New Cancer Nanomedicines - Challenges and Solutions4 Risks Associated with Nanotechnology5 Standards and Regulation6 Nanotechnology and the Public7 Additional Challenges8 Concluding RemarksReferencesAcronymsGlossaryA AgendaB Speaker and Planning Committee Biographies

DKK 221.00
1

Improving Intergroup Relations Among Youth - Forum On Adolescence - Bog - National Academies Press - Plusbog.dk

Exploring the Adoption of Implantable Brain Stimulation into Standard of Care for Central Nervous System Disorders - Forum On Neuroscience And Nervous

Understanding the Role of the Immune System in Improving Tissue Regeneration - Forum On Regenerative Medicine - Bog - National Academies Press -